Related Experiment Videos
[Hyper- and hypocalcemia: diagnosis and treatment]
J P Casez1, L Villiger, P Jaeger
1Policlinique médicale universitaire, Hôpital de I'lle, Berne.
Revue Medicale De La Suisse Romande
|April 1, 1992
Summary
Abnormal calcemia requires confirmation and interpretation alongside albuminemia. Identifying the source guides treatment, from parathyroidectomy for primary hyperparathyroidism to bisphosphonates for neoplastic hypercalcemia.
Area of Science:
- Endocrinology
- Clinical Chemistry
Context:
- Abnormal calcemia (high or low blood calcium) is a common clinical finding requiring careful diagnostic evaluation.
- Accurate assessment is crucial for appropriate patient management and preventing complications.
Purpose:
- To outline a diagnostic and management strategy for abnormal calcemia.
- To differentiate between parathyroid and non-parathyroid causes of hypercalcemia.
- To provide treatment guidelines for both hypercalcemia and hypocalcemia.
Summary:
- Confirms abnormal calcemia with a second measurement, considering albumin levels.
- Uses intact parathormone levels to distinguish parathyroid from non-parathyroid hypercalcemia.
- Recommends monitoring and avoiding aggravating factors for mild hypocalcemia (≤2.9 mmol/L).
- Suggests rehydration for hypercalcemia (>3 mmol/L).
- Defines parathyroidectomy as the primary treatment for primary hyperparathyroidism.
- Identifies bisphosphonates as first-line treatment for neoplastic hypercalcemia when antitumoral therapy is insufficient.
- Highlights calcium and vitamin D derivatives for correcting hypocalcemia.
Impact:
- Provides a clear, stepwise approach to managing calcemia disorders.
- Facilitates timely and appropriate treatment decisions for patients with hypercalcemia and hypocalcemia.
- Aims to improve patient outcomes by addressing the underlying causes and managing calcium imbalances effectively.